Eculizumab in paroxysmal nocturnal hemoglobinuria

被引：0
|
作者：
Socie, Gerard [1 ]
Varoqueaux, Nathalie [2 ]
de Latour, Regis Peffault [1 ]
机构：
[1] Hop St Louis, INSERM, AP HP, Serv Hematol Greffe,U728, F-75010 Paris, France
[2] Alexion Pharma France, Direct Affaires Med, F-75008 Paris, France
来源：
M S-MEDECINE SCIENCES | 2009年 / 25卷 / 12期
关键词：
COMPLEMENT INHIBITOR ECULIZUMAB; PIG-A GENE; MICROPARTICLES; HEMOLYSIS; DISEASE;
D O I：
10.1051/medsci/200925121126
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Eculizumab in paroxysmal nocturnal hemoglobinuria Paroxysmal nocturnal hemoglobinuria is a rare acquired clonal of the hematopoietic stem cell due to acquired mutation of the PIG-A gene. This results in the lack of two GPI-anchored membrane proteins involved in the inhibition of complement attack, thus explaining red cells hemolysis. The development of an anti-C5 monoclonal antibody (eculizumab) had profoundly modified the treatment of the the hemolytic form of the disease.
引用
收藏
页码：1126 / 1129
页数：4
相关论文
共 50 条
  • [41] Paroxysmal nocturnal hemoglobinuria (PNH) in the eculizumab era: The bedside and beyond
    Risitano, A. M.
    Hill, A.
    Ricci, F.
    Selleri, C.
    Marando, L.
    Gianfaldoni, G.
    Marinelli, F.
    Milano, F.
    Amendola, A.
    Boschetti, C.
    Di Bona, E.
    Barbano, E.
    D'Amico, P.
    Rodeghierc, F.
    Zanella, A.
    Iori, A. P.
    Notaro, R.
    Rother, R. P.
    Kroon, H. A.
    Hillmen, P.
    Luzzatto, L.
    Rotoli, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 89 - 90
  • [42] Eculizumab for paroxysmal nocturnal hemoglobinuria: Two cases of successful pregnancy outcomes
    Ilic, Jovanka
    Pujic, Borislava
    Jakovljevic, Branislava
    Sekulic, Borivoj
    Agic, Danijela
    El Farra, Amir
    Micanovic, Branimir
    Vejnovic, Tihomir
    Urosevic, Ivana
    Savic, Aleksandar
    CLINICAL CASE REPORTS, 2024, 12 (05):
  • [43] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Rother, Russell P.
    Rollins, Scott A.
    Mojcik, Christopher F.
    Brodsky, Robert A.
    Bell, Leonard
    NATURE BIOTECHNOLOGY, 2007, 25 (11) : 1256 - 1264
  • [44] Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, P
    Hall, C
    Marsh, JCW
    Elebute, M
    Bombara, MP
    Petro, BE
    Cullen, MJ
    Richards, SJ
    Rollins, SA
    Mojcik, CF
    Rother, RP
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (06): : 552 - 559
  • [45] Effect of eculizumab administrations on the haemostatic changes in patients with paroxysmal nocturnal hemoglobinuria
    Seregina, E.
    Nikulina, O.
    Tsvetaeva, N.
    Balandina, A.
    Ataullakhanov, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 836 - 836
  • [46] Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Muus, Petra
    Duhrsen, Ulrich
    Risitano, Antonio M.
    Schubert, Jorg
    Luzzatto, Lucio
    Schrezenmeier, Hubert
    Szer, Jeffrey
    Brodsky, Robert A.
    Hill, Anita
    Socie, Gerard
    Bessler, Monica
    Rollins, Scott A.
    Bell, Leonard
    Rother, Russell P.
    Young, Neal S.
    BLOOD, 2007, 110 (12) : 4123 - 4128
  • [47] Eculizumab treatment in pregnant women with paroxysmal nocturnal hemoglobinuria: A Polish experience
    Czyz, Jaroslaw
    Szukalski, Lukasz
    Szukalska, Adriana
    Budziszewska, Bozena Katarzyna
    Lech-Maranda, Ewa
    Zdziarska, Joanna
    Sacha, Tomasz
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 31 (06): : 707 - 710
  • [48] Hereditary Hemochromatosis Manifesting After Treatment of Paroxysmal Nocturnal Hemoglobinuria With Eculizumab
    Elliott, Elizabeth
    Waheed, Salman
    Syed, Sahr
    Eswaran, Sheila
    Gregory, Stephanie
    Shammo, Jamile
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (01): : E9 - E12
  • [49] Pegcetacoplan for Breakthrough Hemolysis in an Adolescent With Classical Paroxysmal Nocturnal Hemoglobinuria on Eculizumab
    Njeru, Catherine
    Baker, Danielle
    Merkeley, Hayley
    Amid, Ali
    PEDIATRIC BLOOD & CANCER, 2025, 72 (05)
  • [50] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Russell P Rother
    Scott A Rollins
    Christopher F Mojcik
    Robert A Brodsky
    Leonard Bell
    Nature Biotechnology, 2007, 25 : 1256 - 1264
12345